Personal CFO Solutions’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Personal CFO Solutions’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,000	Closed	-$82K	–	505
2022 Q3	$82K	Hold	10,000	–	–	0.02%	398
2022 Q2	$66K	Hold	10,000	–	–	0.02%	418
2022 Q1	$56K	Hold	10,000	–	–	0.01%	457
2021 Q4	$47K	Sell	10,000 -13,000	-57%	-$80.6K	0.01%	465
2021 Q3	$142K	Hold	23,000	–	–	0.03%	435
2021 Q2	$152K	Hold	23,000	–	–	0.03%	415
2021 Q1	$168K	Buy	23,000 +10,000	+77%	+$86.3K	0.04%	386
2020 Q4	$75K	Hold	13,000	–	–	0.02%	365
2020 Q3	$0	Buy	+13,000	New	+$64.3K	﹤0.01%	358
2020 Q1	–	Sell	-5,390	Closed	-$34K	–	393
2019 Q4	$34K	Buy	+5,390	New	+$39.7K	0.01%	340

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Personal CFO Solutions's AVEO Position: Q4 2022 in Review

Personal CFO Solutions sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 10,000 shares — an estimated $82K sold.

Personal CFO Solutions first reported a position in AVEO in Q4 2019 and held it in 10 quarters. The position peaked at $168K in Q1 2021. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Personal CFO Solutions reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Personal CFO Solutions sold 10,000 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $82K.
Personal CFO Solutions first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2019 and held it in 10 quarters.
Personal CFO Solutions's AVEO Pharmaceuticals, Inc. position peaked at $168K in Q1 2021.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Personal CFO Solutions's 13F filing for Q4 2022, filed 14 Feb 2023.